Background: Limited information is available on the predictors of neurocognitive (NC) decline in individuals with good virological control. Identification of modifiable risk factors that predict decline would support the development of targeted interventions aimed at minimizing NC decline in higher-risk individuals. The objective of the study was to identify baseline factors predicting NC decline over the subsequent 3 years in aviremic individuals.
Methods: As part of the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study, HIV+ individuals were administered 15 neuropsychological tests every 6 months. Group-based trajectory analysis was used to detect patterns of NC change on each test over the course of follow-up. Individuals who deteriorated ≥ 0.5 SD on at least 1 test within the first 36 months of follow-up were considered decliners. Multiple logistic regression was used to identify baseline socio-demographic, clinical, biological and lifestyle factors associated with decline.
Results: 191 patients evaluated semi-annually were aviremic at all time points in the first 3 years; 166 had undergone CSF analysis. Viral presence in CSF was rare (10 /649 person-visits). Among the 191 patients, 23 (12%) declined cognitively over 3 years. In the multivariate analysis, the factors at baseline that met our threshold for predicting NC decline are listed in Table 1. Some risk factors identified in prior cross-sectional studies did not predict decline in this sample: older age, non-white ethnicity, low nadir CD4, CPE score, hepatitis C co-infection, diabetes, hypertension, low hemoglobin, low platelets, or a diagnosis of AIDS.
Conclusions: It is encouraging that cognitive decline over 3 years was uncommon in this sample of aviremic HIV+ individuals. The strongest predictor of decline was eGFR, a known independent predictor of atherosclerotic vascular disease. While an extension of this work in a larger sample will be needed to further clarify the contribution of vascular factors to cognitive decline in aviremic individuals, this work suggests that controlling additional cardio-vascular risk factors could be a useful strategy for minimizing cognitive decline. Modifiable risk factors were very common in the entire cohort, with as many as 80% reporting either smoking or a BMI ≥ 25. Smoking cessation and avoidance of obesity would be obvious starting points to maintain brain health.
| Risk Factor [Reference level] | Odds Ratio | 95% Confidence interval |
| eGFR ≤ 50 mL/min [> 50] | 6.80 | 1.35, 34.23 |
| HIV infection ≥ 15 years [0-<5] | 5.45 | 1.19, 25.02 |
| Education ≤ 12 years [> 12] | 4.25 | 1.45, 12.42 |
| CSF protein >45 mg/dL [≤45] | 3.25 | 1.13, 9.35 |